Kandasamy Hariharan

Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic Drugs

Aïcha Demidem, Tammy Lam, Steve Alas et al. · Cancer Biotherapy and Radiopharmaceuticals · 1997 · 397 citations

A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity

Jianying Dong, Arlene Sereno, Dikran Aivazian et al. · mAbs · 2011 · 78 citations · Full text

Tumor Biology, Single Mabs, Parental Monoclonal Antibodies +14

Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines

Nuzhat I. Pathan, Peter Chu, Kandasamy Hariharan et al. · Blood · 2007 · 72 citations · Full text

Modification of the Fc Region of a Primatized IgG Antibody to Human CD4 Retains Its Ability to Modulate CD4 Receptors but Does Not Deplete CD4+ T Cells in Chimpanzees

Roland Newman, Kandasamy Hariharan, Mitchell E. Reff et al. · Clinical Immunology · 2001 · 64 citations

Primatized Igg Antibody, Autoimmune Disease, Fc Region +9

Rituximab-Mediated Cell Signaling and Chemo/Immuno-sensitization of Drug-Resistant B-NHL Is Independent of Its Fc Functions

Mario I. Vega, Sara Huerta‐Yépez, Melisa Martinez-Paniagua et al. · Clinical Cancer Research · 2009 · 60 citations · Full text